These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 21530826

  • 1. Peptide and recombinant immunotherapy.
    Larché M.
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [Abstract] [Full Text] [Related]

  • 2. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 3. Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches.
    Larché M.
    Pharmacol Ther; 2005 Dec; 108(3):353-61. PubMed ID: 16014312
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy with peptides.
    Moldaver D, Larché M.
    Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
    [Abstract] [Full Text] [Related]

  • 5. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 6. Update on the current status of peptide immunotherapy.
    Larché M.
    J Allergy Clin Immunol; 2007 Apr; 119(4):906-9. PubMed ID: 17418662
    [Abstract] [Full Text] [Related]

  • 7. Allergen immunotherapy with cat allergen peptides.
    Kay AB, Larché M.
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):391-9. PubMed ID: 15007637
    [Abstract] [Full Text] [Related]

  • 8. Prospects for peptide-based immunotherapy for dog allergy.
    Virtanen T.
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652
    [Abstract] [Full Text] [Related]

  • 9. The current state of recombinant allergens for immunotherapy.
    Pauli G, Malling HJ.
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [Abstract] [Full Text] [Related]

  • 10. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Dec; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

  • 11. Recombinant allergens for specific immunotherapy.
    Cromwell O, Häfner D, Nandy A.
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F.
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 15. Peptide immunotherapy.
    Larché M.
    Immunol Allergy Clin North Am; 2006 May; 26(2):321-32, viii. PubMed ID: 16701147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R, Huang HJ, Freidl R, Linhart B, Vrtala S, Wekerle T, Karaulov A, Valenta R.
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [Abstract] [Full Text] [Related]

  • 18. Peptide immunotherapy for allergic diseases.
    Larché M.
    Allergy; 2007 Mar; 62(3):325-31. PubMed ID: 17298351
    [Abstract] [Full Text] [Related]

  • 19. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD, Valmonte GR, de Guia RM.
    Protein Pept Lett; 2007 Mar; 14(10):992-1002. PubMed ID: 18220997
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.